You searched for Parkinson's - Page 13 of 20

Best in Biotech 26 Nov 2024

Seven miRNA-focused companies pioneering new therapies in 2024

…program, reporting broad biodistribution across the brain and effective target engagement. These results support the progression of BMD-001 toward formal clinical studies for Alzheimer’s disease, ALS, and Parkinson’s disease. Cardior…

November 26, 2024 - 9 minutesmins - By Jules Adam

News and Trends 18 Mar 2016

Biotech of the Week: Addex Therapeutics, a Swiss Biotech on a Rollercoaster ride

…company also announced the completion of the mGlu5 receptor occupancy study with dipraglurant with a healthy volunteer. Funded by the Michael J. Fox Foundation for Parkinson’s Research (MJFF), this trial…

March 18, 2016 - 2 minutesmins - By Joachim Eeckhout

Biotech deals partnerships and MA tracker

2024 biotech deals tracker: the latest partnerships and M&A

…November 2024: Vesalius, based in the United States, has partnered with GSK, based in the United Kingdom, to develop treatments for Parkinson’s disease. Vesalius is eligible to receive $80 million…

March 7, 2024 - 1 minutemin - By Aurore Michelin

Interview 10 Apr 2017

“Alzheimer’s is the Last Unclaimed Therapeutic Space,” says TauRx exec

…planning to expand? Yes, but that requires money. We do have a very interesting candidate for Parkinson’s though, which outperforms LMTX to Alzheimer’s in an in vitro model. This is…

April 10, 2017 - 7 minutesmins - By Evelyn Warner

News and Trends 12 Sep 2016

Grüßgott, get to Meet 9 exciting Biotechs from Vienna

…a threat. AFFiRis is evaluating this strategy in 3 Phase I studies, for diseases like high cholesterol, multiple system atrophy, and Parkinson’s. Zytoprotec started out in 2007 and is…

September 12, 2016 - 6 minutesmins - By Denise Neves Gameiro

News and Trends 19 Dec 2017

Schizophrenia and Drug Delivery Biotechs Sign a Major Pharma Partner

Santa Claus is not the only busy one in the weeks leading up to Christmas this year, with Boehringer Ingelheim signing collaborations with Autifony and Evox Therapeutics. In the last…

December 19, 2017 - 2 minutesmins - By Alex Dale

News and Trends 2 May 2023

Single-molecule valve breakthrough could lead to early disease diagnosis

…help with detecting very small amounts of pathogens for early diagnosis of diseases such as cancers and Parkinson’s disease, without requiring expensive equipment.” The findings of this study could be…

May 2, 2023 - 2 minutesmins - By Jim Cornall

cancer cell screening drug discovery microplate

News and Trends 7 Oct 2022

GATC AI platform reduces time to find opioid use disorder candidates

…of medicine.” With the platform’s new drug discovery, GATC has the potential to improve other treatments such as addiction, post-traumatic stress disorder (PTSD), Alzheimer’s disease, Parkinson’s disease, major depressive disorder…

October 7, 2022 - 3 minutesmins - By Jim Cornall

guitar singing music song Rawpixel.com fi

News and Trends 26 Oct 2016

Proteins can now Sing about their Anomalies to help cure Diseases

…degenerative diseases like Alzheimer’s and Parkinson’s. Sonification could also be applied to gene sequences to identify targets for CRISPR therapies and cure genetic disease. Beyond all of these potential uses,…

October 26, 2016 - 3 minutesmins - By Evelyn Warner

In Depth 14 Apr 2025

Metabolomics: The study of biology’s dark matter

…die on the vine because they didn’t hit their clinical readout. Metabolomics can help as a diagnostic tool in fields where the readout is just not as rich, like Parkinson’s…

April 14, 2025 - 7 minutesmins - By Jules Adam

News and Trends 9 Jul 2018

Swedish Alzheimer’s Treatment Slows the Disease in Phase II Trial

…other diagnostics for neurodegenerative diseases. The company is partnering with Eisai and AbbVie on projects for Alzheimer’s and Parkinson’s disease, respectively. BioArctic’s stock price increased by a staggering 400% three…

July 9, 2018 - 3 minutesmins - By Alexander Burik

neurimmune ono pharmaceutical neurodegenerative disease

More News! 9 Nov 2017

Swiss Biotech and Japanese Pharma Team Up to Tackle Neurodegenerative Disease

…disease proteins. Using this technology, the company has built a pipeline of promising candidates against neurodegenerative diseases like Alzheimer’s, Parkinson’s, and amyotrophic lateral sclerosis (ALS). Last year, the Swiss biotech…

November 9, 2017 - 1 minutemin - By Clara Rodríguez Fernández

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Parkinson's

Seven miRNA-focused companies pioneering new therapies in 2024

Biotech of the Week: Addex Therapeutics, a Swiss Biotech on a Rollercoaster ride

2024 biotech deals tracker: the latest partnerships and M&A

“Alzheimer’s is the Last Unclaimed Therapeutic Space,” says TauRx exec

Grüßgott, get to Meet 9 exciting Biotechs from Vienna

Schizophrenia and Drug Delivery Biotechs Sign a Major Pharma Partner

Single-molecule valve breakthrough could lead to early disease diagnosis

GATC AI platform reduces time to find opioid use disorder candidates

Proteins can now Sing about their Anomalies to help cure Diseases

Metabolomics: The study of biology’s dark matter

Swedish Alzheimer’s Treatment Slows the Disease in Phase II Trial

Swiss Biotech and Japanese Pharma Team Up to Tackle Neurodegenerative Disease

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!